To investigate the mechanism of HMGB3 knockdown-mediated colorectal cancer inhibition, we detected that knockdown of HMGB3 decrease mesenchymal markers (N-cadherin, Vimentin) as well as the key factors of WNT/β-catenin signaling pathway (β-catenin). The gene discussed is CDH2; the disease is colorectal cancer.